Ország: Írország
Nyelv: angol
Forrás: HPRA (Health Products Regulatory Authority)
GONADOTROPHIN EQUINE SERUM, GONADOTROPHIN CHORIONIC
Intervet Ireland Limited
QG03GA99
GONADOTROPHIN EQUINE SERUM, GONADOTROPHIN CHORIONIC
International Unit
Pdr+Solv for Soln for Inj
POM
Porcine
Gonadotropins, combinations
Hormone
Authorised
1989-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT PG 600 Powder and solvent for solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each reconstituted 5 ml dose contains: Active Substances Chorionic gonadotrophin 200 IU Serum gonadotrophin 400 IU For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Powder and solvent for solution for injection. Sterile white powder supplied with clear, colourless solvent. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _Gilts: _Administration of a single dose of PG 600 to gilts over the age of five months will normally result in a fertile oestrus within five days. _Sows post-weaning: _To promote early post-partum oestrus (particularly where early weaning is practised) it is recommended that a single injection of PG 600 be given within 48 hours of weaning. _Barren sows: _Cases of suboestrus or anoestrus due to hormonal imbalance may respond favourably to a single dose of PG600, exhibiting normal heat within five days of injection. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active substance. Do not inject into the subcutaneous fat. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 17/10/2016_ _CRN 7024128_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTION(S) FOR USE IN ANIMALS None. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS In case of accidental self-injection seek medical advice and show the package leaflet to the physician. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) In the Olvassa el a teljes dokumentumot